This mammogram depicts breast bearing malignant tumor.
CREDIT
Houston Methodist
Researchers at Houston Methodist have developed an artificial intelligence (AI) software that reliably interprets mammograms, assisting doctors with a quick and accurate prediction of breast cancer risk. According to a new study published in Cancer (early online Aug. 29), the computer software intuitively translates patient charts into diagnostic information at 30 times human speed and with 99 percent accuracy.
“This software intelligently reviews millions of records in a short amount of time, enabling us to determine breast cancer risk more efficiently using a patient’s mammogram. This has the potential to decrease unnecessary biopsies,” says Stephen T. Wong, Ph.D., P.E., chair of the Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute.
The team led by Wong and Jenny C. Chang, M.D., director of the Houston Methodist Cancer Center used the AI software to evaluate mammograms and pathology reports of 500 breast cancer patients. The software scanned patient charts, collected diagnostic features and correlated mammogram findings with breast cancer subtype. Clinicians used results, like the expression of tumor proteins, to accurately predict each patient’s probability of breast cancer diagnosis.
In the United States, 12.1 million mammograms are performed annually, according to the Centers for Disease Control and Prevention (CDC). Fifty percent yield false positive results, according to the American Cancer Society (ACS), resulting in one in every two healthy women told they have cancer.
Currently, when mammograms fall into the suspicious category, a broad range of 3 to 95 percent cancer risk, patients are recommended for biopsies.
Over 1.6 million breast biopsies are performed annually nationwide, and about 20 percent are unnecessarily performed due to false-positive mammogram results of cancer free breasts, estimates the ACS.
The Houston Methodist team hopes this artificial intelligence software will help physicians better define the percent risk requiring a biopsy, equipping doctors with a tool to decrease unnecessary breast biopsies.
Manual review of 50 charts took two clinicians 50-70 hours. AI reviewed 500 charts in a few hours, saving over 500 physician hours.
“Accurate review of this many charts would be practically impossible without AI,” says Wong.
Learn more: Artificial intelligence expedites breast cancer risk prediction
The Latest on: Breast cancer risk prediction
via Google News
The Latest on: Breast cancer risk prediction
- Mammographic Density, Breast Cancer Risk and Risk Predictionon November 12, 2019 at 4:00 pm
Recently, this risk factor has been added to existing breast cancer risk prediction models, increasing the discriminatory accuracy with its inclusion, albeit slightly. With validation, these models ...
- Cancer Meeting Roundup: Prediction, Screening, Detectionon November 5, 2019 at 9:33 am
In men, elevated levels of two hormones -- insulin-like growth factor-I (IGF-I) and free testosterone -- were linked to an increased risk of prostate cancer ... Early Look at a Blood Test for Breast ...
- Artificial intelligence expedites breast cancer risk predictionon October 23, 2019 at 5:00 pm
HOUSTON, TX, UNITED STATES - Sep 1, 2016 - Researchers at Houston Methodist have developed an artificial intelligence (AI) software that reliably interprets mammograms, assisting doctors with a quick ...
- Polygenes, Risk Prediction, and Targeted Prevention of Breast Canceron September 18, 2019 at 5:00 pm
The clinical use of single, common, low-penetrance genes is limited, but a few susceptibility alleles may distinguish women who are at high risk for breast cancer from those who are at low risk, ...
- Polygenes, Risk Prediction, and Targeted Prevention of Breast Canceron September 18, 2019 at 5:00 pm
Breast cancer tends to cluster in families ... Most reported genetic associations have been false positive results and would be worthless for risk prediction. 31 The evidence providing support for ...
- Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysison September 12, 2019 at 5:00 pm
that is expected to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary ...
- AI on XSEDE Systems Promises Early Prediction of Breast Canceron September 9, 2019 at 8:00 am
Short-term breast cancer risk prediction from negative screening digital mammograms (first row). Second row shows heatmaps illustrating the deep learning-identified regions that are associated with ...
- Deep Learning AI on XSEDE Systems Promises Fewer False Alarms and Early Prediction of Breast Canceron September 9, 2019 at 7:30 am
But doctors wonder whether “normal” images contain clues about a woman’s risk of developing breast cancer in the future ... classifier has no predictive value and one implies perfect prediction.
- Biomarkers of DNA methylation can be a predictor of breast cancer riskon June 27, 2019 at 5:32 am
Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk, according to a study published ... and then applied the prediction models to a large genetic ...
- Tailoring breast cancer screening to individual patient riskon April 11, 2019 at 8:00 am
and breast density. For a group of women in the study we’ll calculate their risk of cancer using the BOADICEA model and then validate it against the actual number of cancers detected. Ultimately, if ...
via Bing News
 software that reliably interprets mammograms, assisting doctors with a quick and){kind=link}